M3-Brigade Acquisition V (NASDAQ:MBAV) is a special purpose acquisition company (SPAC) sponsored by M3 Inc., a global healthcare information and technology provider, and Brigade Capital Management, an investment management firm. The company is structured as a blank‐check vehicle listed on the Nasdaq Stock Market under the ticker MBAV, with the objective of identifying and completing a business combination in the healthcare, life sciences or related sectors.
The company benefits from the operational expertise of M3’s digital health platform and real‐world data capabilities, combined with Brigade’s deep experience in credit and asset management. M3-Brigade Acquisition V seeks to leverage this complementary skill set to pursue partnerships or acquisitions of target businesses that possess strong management teams, differentiated products or services, and scalable growth potential.
M3-Brigade Acquisition V’s investment mandate is global in scope, with a focus on companies operating in North America, Europe and Asia. Potential targets may include providers of clinical decision support, data analytics, medical devices, contract research services and other technology‐enabled solutions that address evolving needs across healthcare delivery, commercialization and patient engagement.
The SPAC is managed by a leadership team with decades of combined experience in healthcare operations, research and investment management. Through its dual sponsorship model, M3-Brigade Acquisition V aims to accelerate value creation by providing target companies with capital, industry connections and strategic guidance to drive innovation and long-term growth.
